[Immunomonitoring of patients treated with CAR-T cells for hematological malignancy: Guidelines from the CARTi group and the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)].
Rubio MT, Varlet P, Allain V, Ballot C, Cuffel A, Deschamps M, Ferrand C, Foguenne J, Forcade E, Huynh A, Guihot A, Latouche JB, Lemarie C, Martinroche G, Morin F, Nguyen S, Schmit K, Servais S, Simonetta F, Yakoub-Agha I, Caillat Zucman S.
Rubio MT, et al. Among authors: foguenne j.
Bull Cancer. 2021 Dec;108(12S):S53-S64. doi: 10.1016/j.bulcan.2021.04.008. Epub 2021 Jul 9.
Bull Cancer. 2021.
PMID: 34253335
French.